{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T22:49:46Z","timestamp":1768862986257,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Peritoneal surface metastases (PSMs) from colorectal cancer have high rates of peritoneal recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prior studies dichotomize peritoneal recurrence into \u201cearly\u201d and \u201clate,\u201d limiting insight into how clinicopathologic factors influence recurrence timing. This study aimed to identify predictors of peritoneal recurrence and quantify their continuous association with time to recurrence following CRS\/HIPEC. Methods: Patients undergoing CC-0 CRS\/HIPEC for colorectal PSM from 2018 to 2024 were identified from a prospectively maintained database. The primary outcome was peritoneal surface recurrence. Variables included peritoneal cancer index (PCI), tumor location, histology, HIPEC regimen, and KRAS\/BRAF\/SMAD4 status. Factors with p &lt; 0.10 on univariable analysis were entered into multivariable logistic regression (recurrence: yes\/no) and linear regression (time to recurrence). Results: Among 133 patients, 64 (48.1%) developed peritoneal recurrence. Median time to recurrence was 41.4 weeks (IQR 24.9\u201374.0), and PCI was higher among those who recurred (median 11.0 vs. 5.0, p &lt; 0.01). Neither tumor stage, histology, intraperitoneal chemotherapy agent, nor molecular alterations were associated with increased risk of peritoneal recurrence. When controlling for PCI, right- and sigmoid-colon primaries independently predicted peritoneal recurrence compared to all other locations without influence on recurrence timing (right: OR 7.18; sigmoid: OR 6.54; p &lt; 0.01). Among patients who recurred, each one-point increase in PCI corresponded to a 2.43-week earlier relapse (p &lt; 0.01). Conclusions: Nearly half of patients with colorectal PSM recurred despite complete CRS\/HIPEC. Tumor location predicted peritoneal recurrence, while PCI independently shortened time to relapse. Modeling PCI as a continuous predictor refines postoperative risk stratification and may inform individualized surveillance strategies.<\/jats:p>","DOI":"10.3390\/cancers18020299","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:57:02Z","timestamp":1768816622000},"page":"299","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of Peritoneal Surface Recurrence and Quantitative Association with Time to Relapse After Complete CRS\/HIPEC for Colorectal Peritoneal Metastasis"],"prefix":"10.3390","volume":"18","author":[{"given":"Corey A.","family":"Hounschell","sequence":"first","affiliation":[{"name":"Providence Saint John\u2019s Cancer Institute, Santa Monica, CA 90404, USA"},{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubrey C.","family":"Swilling","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahaam","family":"Mirza","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-8378","authenticated-orcid":false,"given":"Katelyn","family":"Sanner-Dixon","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Haley","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke V.","family":"Selby","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid","family":"Umar","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin","family":"Al-Kasspooles","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br. J. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: An analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sun, B.J., Daniel, S.K., and Lee, B. (2023). The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer. J. Clin. Med., 12.","DOI":"10.3390\/jcm12206443"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20180102","DOI":"10.1515\/pp-2018-0102","article-title":"Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: Surgeon\u2019s perspective","volume":"3","author":"Franko","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: A multi-institutional study of 1290 patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1245\/s10434-016-5211-6","article-title":"Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC","volume":"23","author":"Simkens","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-021-10049-3","article-title":"The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases","volume":"28","author":"Bijelic","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1245\/s10434-016-5488-5","article-title":"Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases","volume":"24","author":"Baratti","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12957-025-03736-y","article-title":"Evaluating long-term outcomes after cytoreductive surgery for colorectal peritoneal metastasis: Do long survivors really exist?","volume":"23","author":"Aulicino","year":"2025","journal-title":"World J. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/ASO.2004.08.014","article-title":"Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: Location, treatment, and outcome","volume":"11","author":"Verwaal","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jso.23597","article-title":"Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"109","author":"Braam","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1245\/s10434-018-6860-4","article-title":"Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience","volume":"26","author":"Feferman","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejso.2022.07.019","article-title":"Patterns and Timing of Recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis","volume":"49","author":"Hassan","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/bjs.4516","article-title":"Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"91","author":"Verwaal","year":"2004","journal-title":"Br. J. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","article-title":"Mutations of RAS\/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin","volume":"268","author":"Schneider","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1245\/s10434-019-07452-2","article-title":"Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC","volume":"27","author":"Graf","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10147-018-1301-8","article-title":"Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Tan","year":"2018","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"110501","DOI":"10.1016\/j.ejso.2025.110501","article-title":"Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases: Insights from the Dutch CRS-HIPEC registry","volume":"51","author":"Hemmer","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1245\/s10434-024-15942-1","article-title":"Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","volume":"31","author":"Allievi","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1245\/s10434-023-14840-2","article-title":"Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence","volume":"31","author":"Grange","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"978394","DOI":"10.1155\/2013\/978394","article-title":"Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy","volume":"2013","author":"Yonemura","year":"2013","journal-title":"Sci. World J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/annonc\/mdu275","article-title":"Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features","volume":"25","author":"Missiaglia","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1002\/cam4.3243","article-title":"A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer","volume":"9","author":"Rovers","year":"2020","journal-title":"Cancer Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"86356","DOI":"10.18632\/oncotarget.21169","article-title":"Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers","volume":"8","author":"Salem","year":"2017","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","article-title":"Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis","volume":"22","author":"Simkens","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","article-title":"Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/2\/299\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:05:22Z","timestamp":1768817122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/2\/299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["cancers18020299"],"URL":"https:\/\/doi.org\/10.3390\/cancers18020299","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}